™
middle.
Gathering signals...
™
middle.
Browse
middle.
Latest
Sectors
All Sectors
Health
Technology
Finance
Energy
Property
Consumer
Moves
M&A
Capital Raises
Listings & IPOs
Boardroom Shifts
Strategy Changes
Signals
Price Spikes
Regulatory Filings
Insider Trades
Class Actions
Sentiment Moves
Light
Dark
Auto
Sign in
Join the waitlist
Home
Tags
Neurotherapeutics
Page 2
Latest Neurotherapeutics News
Page 2 of 2
Argenica’s Phase 2 Stroke Trial Clears Safety Hurdle, Nears Completion
Argenica Therapeutics has received a positive safety review from its independent DSMB for the Phase 2 trial of ARG-007 in acute ischaemic stroke patients, with dosing now 86% complete and full recruitment expected by early Q2 2025.
Ada Torres
30 Jan 2025
1
2
Browse the archive
Full archive
Nov 2026
Oct 2026
Sept 2026
Aug 2026
July 2026
June 2026
May 2026
Apr 2026
Top